Saturday, October 31, 2026

Will Bitcoin Reach 100,000 USD by Year-End? Insights from Standard Chartered’s Latest Forecast

Standard Chartered predicts Bitcoin could reach 100,000 USD by year-end, boosted by the U.S. Treasury's expanded long-term bond buyback.

Artemis 2 to Carry CubeSat Testing Samsung’s Next-Gen Space Chips

Samsung and SK Hynix will validate advanced semiconductors in NASA's Artemis 2 mission, focusing on radiation-resistant technologies.

America First, Again? Trump-Era Strategy Resurfaces in Asia Military Plans

The U.S. is revisiting the role of its troops in South Korea, citing defense cost sharing and the need to counter China.

Health

Unlock Your Health: Discover the New AI-Powered BioAge and Health Coach Services from DaNaA Data

Daewoo Group's AI health data firm, DaNaA Data, launched a service analyzing biological age, disease risk, and health check results.

How the New Medical School in Namwon Can Transform Regional Healthcare: Insights from Lawmaker Park Ji-won

Defining school locations alone won't solve local healthcare issues; deeper strategies are needed for effective solutions.

Ardens Lifescience Triumphs: How a Korean Startup Won 175,000 USD at MedTech Innovator APAC 2026

Adenz Life Sciences wins a global medical device competition, earning a prize of 175,000 USD.

Unlocking the Future of Healthcare: Daewoong’s AI-Powered Smart Hospital at AI EXPO MARS 2026

Daewoong Pharmaceutical introduces an AI-based smart hospital model for monitoring, diagnosis, testing, and rehabilitation.

10 Years of Excellence: Seoul’s APLAR Center Hosts International Rheumatology Training for Young Specialists

Seoul St. Mary's Hospital's Rheumatology Center held an international training program for foreign experts on October 27 and 26.
Latest

L&K Biomed Wins Additional U.S. FDA Approval, Expanding Spinal Implant Options

L&K Biomed has secured additional FDA approval for expanded BluEX-C sizes, giving U.S. physicians more options for cervical spine implants tailored to individual patient anatomy.

2026 Guide to Stem Cell Therapy: Understanding Costs and Treatment Types in Asia

Celebrities, including Kim Kardashian, have increased public interest in stem cell treatments in Korea.

Deepnoid Proves Top-Tier Global Standing in Cerebrovascular AI Benchmark

Deepnoid’s AI technology for analyzing cerebrovascular images has demonstrated strong performance in an international benchmark study.

Blood Drop Could Enable Vascular Disease Diagnosis in Just 10 Minutes

South Korean researchers have developed a rapid diagnostic platform that can analyze vascular disease-related molecular signals from a single drop of plasma in about 10 minutes.

Noul Secures Health Canada Approval for AI-Powered miLab MAL Malaria Diagnostic Device

AI-based diagnostic company Noul gains approval for malaria diagnostic device in Canada, accelerating its entry into the North American market.

MediPost Signs CDMO Agreement With Qstem for Dermal Papilla Cell Culture Medium

MediPost will establish a commercial-scale production system for Qstem’s hiPSC-based dermal papilla cell culture medium, expanding its CDMO business beyond cell therapies.

Celltrion Completes Integration of France’s Gifrer, Targets European Pharmacy Network

Celltrion has completed the post-acquisition integration of French health care company Gifrer and plans to use its pharmacy network as a hub for expanding direct sales across Europe.

JW Pharmaceutical Files for South Korea Phase 3 Trial of Once-Every-Two-Weeks Obesity Drug

JW Pharmaceutical is seeking to advance Bofanglutide into a South Korean Phase 3 trial, aiming to halve the dosing frequency of GLP-1 obesity treatments from once weekly to once every two weeks.

HLB Panagene Posts Operating Profit in First Half, Accelerates PNA Business Expansion

HLB Panagene remained profitable in the first half as it expands its PNA business and accelerates development of antibody-oligonucleotide conjugates.

Celltrion Publishes Population Pharmacokinetic Analysis of Vegzelma in International Journal

Celltrion has published integrated population pharmacokinetic analysis results for its Avastin biosimilar Vegzelma, confirming pharmacokinetic similarity with the reference drug.

“Preparing for the Next Pandemic After COVID-19”…South Korea Accelerates Development of Homegrown mRNA Vaccines

The South Korean government is accelerating domestic mRNA vaccine development to secure an independent vaccine technology platform capable of responding rapidly to future pandemics.

BMI2012: South Korea’s Next-Gen mRNA COVID-19 Vaccine Set for Clinical Trials

A consortium has received approval for the clinical trial of an mRNA-based COVID-19 variant vaccine, BMI2012.

Bonjo Capsule: A Game-Changer for Severe Myelofibrosis Patients – Here’s Why

The South Korean MFDS has approved a rare drug, Vonjo Capsule (Pacritinib Citrate), for treating myelofibrosis.

U.S. Military Resumes COVID-19 Inspections: What This Means for South Korea in 2026

The Korea Disease Control Agency and the U.S. military will resume quarantine operations for military and contracted aircraft post-COVID-19.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.